Capsaicin binds to TRPV1 receptors throughout the enteric nervous system — your gut's own neural network. This activates the muscle contractions responsible for moving food forward. Published studies show capsaicin directly alleviates impaired intestinal motility by regulating enteric motor neurons, making it the cornerstone of a constipation-focused formula.

Curcumin modulates NF-κB inflammatory pathways in the gut wall, strengthens tight junction proteins that maintain the intestinal lining, and has demonstrated reductions in IBS symptom severity across multiple randomized trials. A 2025 RCT confirmed curcumin also improves constipation and intestinal transit via its effect on gut motility and microbial composition.

Berberine regulates bowel transit through mu- and delta-opioid receptor pathways, reduces visceral hypersensitivity, and alters gut microbiota composition in a manner that correlates with reduced IBS severity. When combined with curcumin, it demonstrated synergistic effects on bowel regularity in 146 IBS patients.

Vitamin D receptors are expressed directly on intestinal smooth muscle cells. Deficiency is now recognised as an independent risk factor for chronic functional constipation. A prospective case-control study of 86 constipated patients found significantly lower vitamin D levels with a strong correlation to impaired colonic transit time.

Piperine increases the intestinal absorption of co-administered compounds by inhibiting metabolic enzymes and efflux transporters in the gut wall. The landmark human pharmacokinetic trial found that 20mg of piperine increased curcumin bioavailability by 2,000% in healthy volunteers — without adverse effects.

Ginseng ginsenosides act on the enteric nervous system to stimulate gastrointestinal motility and support gastric emptying. Its adaptogenic properties also buffer stress-related gut dysfunction, a known driver of functional constipation.